Navigation Links
AMRI Signs Agreement for Exclusive License of its Tubulin Inhibitor Program for Cancer
Date:2/11/2013

oach that attacks key drug development and financing challenges while advancing an innovative portfolio of product candidates. Bessor operates as a semi-virtual organization with a top team of pharmaceutical R&D and business experts and set of partners that function as a fully-integrated pharmaceutical network.

AMRI Forward-Looking Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Readers should not place undue reliance on our forward-looking statements. The company's actual results may differ materially from such forward-looking statements as a result of numerous factors, some of which the company may not be able to predict and may not be within the company's control. Factors that could cause such differences include, but are not limited to: (a) Bessor Pharma's and  Chai Therapeutics' ongoing ability to raise funding for the ALB 109564(a) research and clinical trial program; (b) problems or delays which may arise during clinical trials or in the course of developing, testing or manufacturing these compounds that could lead Bessor and Chai to discontinue development; (c) positive information about early stage clinical trial results is not necessarily indicative of clinical efficacy and does not ensure that later stage or larger scale clinical trials will be successful, for cancer or any other indication; (d) the planned timing of initiation and completion of clinical trials for ALB-109564(a) are subject to the ability of Bessor and Chai to enroll patients, enter into agreements with clinical trial sites and investigators, and other technical hurdles and issues that may not be resolved; (e) delay or denial of regulatory approvals from the FDA resulting from, among other things, adverse FDA decisions or interpretations of data that differ from AMRI, Bessor or Chai's  interpretations and that may require additional
'/>"/>

SOURCE AMRI
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Deborah Morosini, MD Pathologist and Patient Advocate Signs on as Medical Director and Advisory Board Member of Store-A-Toothâ„¢ Dental Stem Cell Banking
2. Trade Show Display Co. GLM Displays Redesigns Blog
3. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
4. MakeSigns.com Announces New Tri-Fold Scientific Poster Service
5. Florida-Based Team Gemini Signs Recycling Facility Agreement with Solid Waste Authority of Central Ohio
6. Ben-Gurion University develops side-illuminated ultra-efficient solar cell designs
7. Bluechiip Signs Strategic Partnership with Gentris Corporation
8. BioPower Operations Corporation Announces that FTZ Exchange Signs Strategic Alliance with Capacity 360, LLC and Tom Settineri
9. Sanofi Signs Agreement for Type 1 Diabetes Research with Boston Academic Teaching Hospital
10. Life Technologies Signs Licensing Agreement with iPS Academia Japan for Global Patent Portfolio Rights to Induced Pluripotent Stem Cell Technology
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... device," Nobel laureate Herbert Kroemer famously observed, ... found at the junctures where layers of ... of nanotechnology, the interfaces between layers of ... applications in such high-tech favorites as spintronics, ... vast potential of these metal oxide interfaces, ...
(Date:1/15/2014)... Jan. 15, 2014   Niagara Thermal Products ... been selected by Buffalo BioBlower Technologies LLC ("B3") ... of its SBIR Phase 2 award from the ... only comprehensive air purification system that kills all ... pollutants, allergens and organic particulates.  In independent testing ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 ... company developing antibody-drug conjugates for cancer, today announced the ... Board of Directors. Dr Reynolds has over 20 years, ... as Chief Medical Officer at Seattle Genetics. ... time for Oxford BioTherapeutics, as the company completes its ...
(Date:1/15/2014)... -- A study has been launched to ... Formula 1 track could help to tackle the problem ... Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) ... by healthcare provider Simplyhealth. Telemetry technology, which ... the on-track performance of Vodafone McLaren Mercedes Formula 1 ...
Breaking Biology Technology:A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... Dmitriy Ovcharenko, Rich Jarvis, , ... , ... experimental tool for reducing the expression of specific , ... gene function analysis, target , ...
... Ambion's newest line of plasmid siRNA , ... feature polymerase (pol) II promoters that drive transcription , ... an antibiotic resistance gene. , The ... strong promoter is active in a broad range of cell types and , ...
... Trace amounts of ribonuclease (RNase) , ... RNases are , ubiquitous in ... air, on anything touched by bare hands or on anything left , ... , or eliminate RNase contamination. ...
Cached Biology Technology:Delivering siRNAs to Difficult Cell Types 2Delivering siRNAs to Difficult Cell Types 3Delivering siRNAs to Difficult Cell Types 4Delivering siRNAs to Difficult Cell Types 5Delivering siRNAs to Difficult Cell Types 6Delivering siRNAs to Difficult Cell Types 7Drive Long-Term Silencing with CMV Vectors 2Drive Long-Term Silencing with CMV Vectors 3Combat RNase Contamination in the Lab 2Combat RNase Contamination in the Lab 3Combat RNase Contamination in the Lab 4Combat RNase Contamination in the Lab 5
(Date:4/16/2014)... memories improves during childhood, associated with structural changes ... and parietal cortices. New research from UC Davis ... this crucial time. Eventually, that could give insights ... into and during adolescence and affect memory, such ... the middle of the brain, the hippocampus plays ...
(Date:4/16/2014)... composed of Dr. Martin Prechtl, Leo Heim and their ... has discovered a new method of generating hydrogen using ... is of particular interest when it comes to fuel ... and mild hydrogen production using water and formaldehyde", have ... . , Among other applications, the new approach can ...
(Date:4/15/2014)... away in Hartford, Connecticut, a Puerto Rican community is ... that is so authentic it has caught the attention ... Gregory J. Anderson (University of Connecticut) took a close ... markets of Hartford and uncovered evidence that gives new ... using for years: home is in the kitchen. , ...
Breaking Biology News(10 mins):How kids' brain structures grow as memory develops 2The human food connection: A new study reveals more about our relationship to food 2The human food connection: A new study reveals more about our relationship to food 3
... Spanish . , How can it be proved ... have a cognitive problem, such as memory or concentration problems ... and even feign them in order to receive more money ... a pioneering research in Spain. This research was carried out ...
... YORK, Jan. 10 U.S. Market for Personal Safes, a ... for,personal safes will grow by double digits in 2008 and ... personal safes accounted for 36%,of the overall U.S. safes market. ... share. An estimated 300,000 safes are sold each year in,the ...
... Harbor Laboratorys (CSHL) researcher Raffaella Sordella, Ph.D. was awarded ... Conquer Lung Cancer. The two-year grant will fund CSHLs ... genetic mutations that appear to be a trigger in ... deaths in the United States. The mutations, called ...
Cached Biology News:Half of the people suffering from head injuries fake to receive financial help 2Personal Safes Market to Top $308 Million by 2011 2Cold Spring Harbor Laboratory's lung cancer research program awarded $100,000 grant 2
Imject Freund's Complete Adjuvant (FCA)...
... cytoplasmic granules, is a key step ... (e.g. basophils, neutrophils, eosinophils, and mast ... secretory granules contain many proinflammatory mediators ... proteases (Hallgren, 2001). Tryptase, a tetrameric ...
... was developed specifically for reduced mutagenicity to ... in agarose or acrylamide gels. SYBR Safe stain ... but SYBR Safe stain's detection sensitivity is better ... comes as a premixed solution that can be ...
... The S&S Custom Processing Service enables scientists who ... and data analysis software to have their biological ... 16 analytes. Its as easy as 1-2-3 ... quantified in your samples from the S&S antibody ...
Biology Products: